Evidence map›Paper›PMID 34365990›Full record

ReviewJournal of the International Neuropsychological Society : JINS2022

Assessment of Neurocognitive Functions, Olfaction, Taste, Mental, and Psychosocial Health in COVID-19 in Adults: Recommendations for Harmonization of Research and Implications for Clinical Practice.

Lucette A Cysique, Emilia Łojek, Theodore Ching-Kong Cheung, Breda Cullen, Anna Rita Egbert, Jonathan Evans, Maite Garolera, Natalia Gawron, Hetta Gouse, Karolina Hansen and 12 more

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of the International Neuropsychological Society : JINS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Neurophenotypes of COVID-19: Risk factors and recovery outcomes.Brain, behavior, & immunity - health · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 15 institutions in 10 countries.

Lucette A Cysique *Psychology Department, Faculty of Sciences, The University of New South Wales, Sydney, NSW, Australia.ORCID 0000-0002-7711-6373
Emilia Łojek *Department of Clinical Neuropsychology and Psychotherapy, Faculty of Psychology, University of Warsaw, Warsaw, Poland.
Theodore Ching-Kong Cheung *Department of Psychology, University of Toronto; Centre for Neuropsychology and Emotional Wellness, Markham, ON, Canada.ORCID 0000-0002-4406-2444
Breda Cullen *Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Anna Rita Egbert *Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0003-0546-1159
Jonathan Evans *Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Maite Garolera *Neuropsychology Unit, Consorci Sanitari de Terrassa, Barcelona, Spain.
Natalia Gawron *Department of Adult Clinical Psychology, Institute of Psychology, The Maria Grzegorzewska University, Warsaw, Poland.
Hetta Gouse *Department of Psychiatry & Mental Health, University of Cape Town, Cape Town, South Africa.
Karolina Hansen *Department of Clinical Neuropsychology and Psychotherapy, Faculty of Psychology, University of Warsaw, Warsaw, Poland.
Paweł Holas *Department of Clinical Neuropsychology and Psychotherapy, Faculty of Psychology, University of Warsaw, Warsaw, Poland.
Sylwia Hyniewska *Division of Psychology and Language Sciences, University College London, London, UK.
Ewa Malinowska *Department of Clinical Neuropsychology and Psychotherapy, Faculty of Psychology, University of Warsaw, Warsaw, Poland.
Bernice A Marcopulos *Department of Graduate Psychology, James Madison University, Harrisonburg, USA.
Tricia L Merkley *Department of Psychology and Neuroscience Center, Brigham Young University, Brigham, USA.
Jose A Muñoz-Moreno *Infectious Diseases Department, Lluita contra la SIDA Foundation, Germans Trias i Pujol Hospital, Barcelona, Spain.
Clare Ramsden *Tasmanian Health Service, Hobart, Australia.
Christian Salas *Faculty of Psychology, Diego Portales University, Santiago, Chile.
Sietske A M Sikkes *Faculty of Behavioural and Movement Sciences, Department of Clinical, Neuro and Developmental Psychology, Amsterdam University Medical Centers & VU University, Amsterdam, the Netherlands.
Ana Rita Silva *Center for Research in Neuropsychology and Cognitive Behavioral Intervention - CINEICC, University of Coimbra, Coimbra, Portugal.
Imane Zouhar *Department of Psychology, University of Toronto, Toronto, ON, Canada.
NeuroCOVID International Neuropsychology Taskforce
University of Warsaw · PLUniversity of Glasgow · GBUniversity of Toronto · CAAmsterdam University Medical Centers · NLBrigham Young University · USConsorci Sanitari de Terrassa · ESInstitute of Psychology · PLJames Madison University · USRed de Investigación en Sida · ESSt. Michael's Hospital · CAUniversidad Diego Portales · CLUniversity College London · GBUniversity of British Columbia · CAUniversity of Cape Town · ZAUniversity of Coimbra · PT

Funding

Safety and Cognition in Driving (SCID): A proposal to examine functional driving skills in professional drivers in Cape Town.K43TW010361 · FIC · UNIVERSITY OF CAPE TOWN · PI GOUSE, HETTA-MARI · 2016 to 2020
$558k
FIC NIH HHS K43 TW010361
6 · The paper itself

Abstract

objectiveTo propose a set of internationally harmonized procedures and methods for assessing neurocognitive functions, smell, taste, mental, and psychosocial health, and other factors in adults formally diagnosed with COVID-19 (confirmed as SARS-CoV-2 + WHO definition).

methodsWe formed an international and cross-disciplinary NeuroCOVID Neuropsychology Taskforce in April 2020. Seven criteria were used to guide the selection of the recommendations' methods and procedures: (i) Relevance to all COVID-19 illness stages and longitudinal study design; (ii) Standard, cross-culturally valid or widely available instruments; (iii) Coverage of both direct and indirect causes of COVID-19-associated neurological and psychiatric symptoms; (iv) Control of factors specifically pertinent to COVID-19 that may affect neuropsychological performance; (v) Flexibility of administration (telehealth, computerized, remote/online, face to face); (vi) Harmonization for facilitating international research; (vii) Ease of translation to clinical practice.

resultsThe three proposed levels of harmonization include a screening strategy with telehealth option, a medium-size computerized assessment with an online/remote option, and a comprehensive evaluation with flexible administration. The context in which each harmonization level might be used is described. Issues of assessment timelines, guidance for home/remote assessment to support data fidelity and telehealth considerations, cross-cultural adequacy, norms, and impairment definitions are also described.

conclusionsThe proposed recommendations provide rationale and methodological guidance for neuropsychological research studies and clinical assessment in adults with COVID-19. We expect that the use of the recommendations will facilitate data harmonization and global research. Research implementing the recommendations will be crucial to determine their acceptability, usability, and validity.

Indexed as

COVID-19AdultHumansLongitudinal StudiesSARS-CoV-2SmellTasteAssessmentCOVID-19GuidelinesNeuropsychological functions

Identifiers

PMID34365990
PMCPMC8825876
OpenAlexW3189898005

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.